Stuart McPherson Consultant Hepatologist Newcastle

Stuart McPherson Consultant Hepatologist Newcastle: Expert Liver Care and Research

Stuart McPherson Consultant Hepatologist Newcastle leads advanced liver medicine with over a decade of experience. Since joining Newcastle Hospitals in 2010, Professor McPherson has provided exceptional care for patients with liver disease. He currently serves as Head of Department for Liver Medicine, guiding his team toward excellence every day.

Specialist Training and Global Expertise of Stuart McPherson Consultant Hepatologist Newcastle

Stuart completed his undergraduate medical training at St Andrews and Manchester Universities. Afterward, he pursued specialist training in Glasgow and Newcastle. Furthermore, he expanded his expertise with two years of research in Brisbane, Australia, focusing on hepatitis C and fatty liver disease. This international experience strengthens his ability to offer cutting-edge treatments.

Clinical Services Led by Stuart McPherson Consultant Hepatologist Newcastle

At Newcastle Hospitals, Stuart manages a wide range of liver conditions. He runs dedicated clinics for viral hepatitis, fatty liver disease, and cirrhosis. Importantly, in 2017, he led his team to win the Royal College of Physicians Quality Improvement Award. This achievement recognized their innovative care bundle for decompensated cirrhosis, which now improves patient outcomes across most UK centres.

Leadership Roles and Contributions to Hepatology

In addition to clinical work, Stuart holds several key roles. He acts as Deputy Vice President (Hepatology) for the British Society of Gastroenterology. Moreover, he leads the North East and North Cumbria Hepatitis C Operational Delivery Network. He also chairs the BSG/BASL NAFLD Special Interest Group. These roles highlight his commitment to advancing hepatology regionally and nationally.

Research and Innovation in Liver Disease Care

Professor McPherson serves as an Honorary Professor of Hepatology Practice at Newcastle University’s Translational and Clinical Research Institute. His research focuses on improving clinical care pathways for viral hepatitis, cirrhosis, and fatty liver disease. Consequently, he aims to detect and treat these diseases early to prevent progression.

He has led multiple clinical trials evaluating new liver disease treatments. Additionally, Stuart has published over 100 scientific papers in peer-reviewed journals. Currently, he acts as Chief Investigator for the SOLID study. This research evaluates liver fibrosis biomarkers in primary care to develop cost-effective pathways for identifying significant liver disease.